IDR 192.0
(-0.52%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 309.59 Billion IDR | 118.79% |
2022 | 129.85 Billion IDR | 19.45% |
2021 | 108.71 Billion IDR | 4.21% |
2020 | 190.85 Billion IDR | 11.23% |
2019 | 170.16 Billion IDR | 5.44% |
2018 | 171.39 Billion IDR | 258.82% |
2017 | 98.91 Billion IDR | -60.72% |
2016 | 122.53 Billion IDR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 100.55 Billion IDR | 7.11% |
2024 Q1 | 57.82 Billion IDR | -4.63% |
2024 Q3 | 62.37 Billion IDR | 1.83% |
2023 Q1 | 26.76 Billion IDR | -7.59% |
2023 FY | - IDR | 118.79% |
2023 Q4 | 102.48 Billion IDR | 79.17% |
2023 Q3 | 57.2 Billion IDR | 235.68% |
2023 Q2 | 17.04 Billion IDR | -36.34% |
2022 Q4 | 28.96 Billion IDR | -30.85% |
2022 Q3 | 41.88 Billion IDR | 0.31% |
2022 FY | - IDR | 19.45% |
2022 Q2 | 41.76 Billion IDR | 145.23% |
2022 Q1 | 17.02 Billion IDR | -47.38% |
2021 Q4 | 32.35 Billion IDR | -8.12% |
2021 Q1 | 25.97 Billion IDR | 3.41% |
2021 Q2 | 15.1 Billion IDR | -41.84% |
2021 Q3 | 35.21 Billion IDR | 133.12% |
2021 FY | - IDR | 4.21% |
2020 Q4 | 25.12 Billion IDR | -14.87% |
2020 Q2 | 21.22 Billion IDR | -25.41% |
2020 Q3 | 29.5 Billion IDR | 38.99% |
2020 Q1 | 28.46 Billion IDR | 23.11% |
2020 FY | - IDR | 11.23% |
2019 Q1 | 16.93 Billion IDR | -64.54% |
2019 FY | - IDR | 5.44% |
2019 Q3 | 29.43 Billion IDR | 21.18% |
2019 Q4 | 23.11 Billion IDR | -21.47% |
2019 Q2 | 24.29 Billion IDR | 43.46% |
2018 FY | - IDR | 258.82% |
2018 Q3 | 47.75 Billion IDR | 25.88% |
2018 Q4 | 47.75 Billion IDR | 0.0% |
2018 Q2 | 37.93 Billion IDR | -0.0% |
2018 Q1 | 37.93 Billion IDR | 0.0% |
2017 FY | - IDR | -60.72% |
2016 FY | - IDR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
PT Alkindo Naratama Tbk | 108.66 Billion IDR | -184.918% |
PT Inter Delta Tbk | -1.24 Billion IDR | 24984.758% |
PT Suparma Tbk | 352.01 Billion IDR | 12.051% |
PT Tirta Mahakam Resources Tbk | -14.88 Billion IDR | 2179.444% |